Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Wenqing Qi
MP470, a Novel Receptor Tyrosine Kinase Inhibitor, in Combination With Erlotinib Inhibits the HER Family/Pi3k/Akt Pathway and Tumor Growth in Prostate Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
Related publications
Acetylshikonin Inhibits Colorectal Cancer Growth via PI3K/Akt/mTOR Signaling Pathway
Chinese Medicine
PCC0208027, a Novel Tyrosine Kinase Inhibitor, Inhibits Tumor Growth of NSCLC by Targeting EGFR and HER2 Aberrations
Scientific Reports
Multidisciplinary
Combination of Ruthenium Complex and Doxorubicin Synergistically Inhibits Cancer Cell Growth by Down-Regulating PI3K/AKT Signaling Pathway
Frontiers in Oncology
Cancer Research
Oncology
UNBS5162 Inhibits Colon Cancer Growth via Suppression of PI3K/Akt Signaling Pathway
Medecine/Sciences
Biochemistry
Medicine
Genetics
Molecular Biology
Novel HER2 Selective Tyrosine Kinase Inhibitor, TAK-165, Inhibits Bladder, Kidney and Androgen-Independent Prostate Cancer in Vitro and in Vivo
International Journal of Urology
Urology
Targeting the PI3K/AKT Pathway for the Treatment of Prostate Cancer
Clinical Cancer Research
Cancer Research
Oncology
BMP9 Inhibits the Growth of Breast Cancer Cells by Downregulation of the PI3K/Akt Signaling Pathway
Oncology Reports
Medicine
Cancer Research
Oncology
Corrigendum: DT-13 Inhibits Proliferation and Metastasis of Human Prostate Cancer Cells Through Blocking PI3K/Akt Pathway
Frontiers in Pharmacology
Pharmacology
Tyrosine Kinase Signalling in Breast Cancer: ErbB Family Receptor Tyrosine Kinases
Breast Cancer Research
Cancer Research
Oncology
